Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

WHAT'S NEW

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Feb 7 2025

Full Issue

Longer Looks: Interesting Reads You Might Have Missed

Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on CRISPR, MDMA therapy, dementia, gun violence, climate change, and more

Stat: The CRISPR Companies Are Not OK

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably. (Mast, 2/6)

The New York Times: How An Activist Group Helped Torpedo MDMA Therapy 

After more than three decades of planning and a $250 million investment, Lykos Therapeutics’ application for the first psychedelic drug to reach federal regulators was expected to be a shoo-in. Lykos, the corporate arm of a nonprofit dedicated to winning mainstream acceptance of psychedelics, had submitted data to the Food and Drug Administration showing that its groundbreaking treatment for post-traumatic stress disorder — MDMA plus talk therapy — was significantly more effective than existing treatments. (Jacobs and Nuwer, 2/4)

The New York Times: These Settings Aren’t Real. But For Dementia Patients, What Is? 

The nursery at RiverSpring Residences in the Bronx is a sunny, inviting space outfitted with a bassinet, a crib with a musical mobile, a few toys, bottles, picture books for bedtime reading and a rack of clothing in tiny sizes. The other morning, Wilma Rosa was there trying to soothe one of its cranky, small charges. “What’s the matter, baby?” she crooned, patting the complainer’s back. “You OK? I want you to go to sleep for a little while.”Ms. Rosa, 76, a memory care resident in assisted living, visits the nursery daily. She has had plenty of experience with babies. (Span, 2/1)

The New York Times: How Weight-Loss Drugs Can Upend a Marriage

Doctors warn about their physical side effects, but they can also have unexpected effects on intimacy. (Miller, 2/2)

NBC News: What Everyone Should Know On Tracking Blood Sugar Levels With Continuous Glucose Monitoring

Is there a benefit for healthy people to track their blood sugar? Measuring blood sugar has joined sleep and exercise tracking as wellness trends, with some longevity experts claiming that reducing fluctuations throughout the day can help protect against heart disease, even for people who don’t have diabetes. Continuous glucose monitors, or CGMs, are small devices that track blood sugar in real time and can tell wearers how their bodies are reacting to stress, food, sleep or exercise. (Syal, Venkatesan and Tobia, 2/2)

The Washington Post: Children Joked About School Shootings. Then The Sheriff Sent Them To Jail. 

An analysis of news reports by The Washington Post found that at least 477 people — 90 percent of them students — were arrested in the two weeks after the Georgia massacre at Apalachee High. That’s nearly 100 more than in the aftermaths of the three previous mass school shootings combined. (Cox and Natanson, 2/3)

The New York Times: The Way Hurricanes Kill Is Changing. Helene Shows How. 

Over the last three months, The New York Times collected data on Helene’s deaths from county coroners and state officials, and interviewed family members. The findings revealed that rain, which led to flooding and landslides, was the most deadly part of the storm, followed by wind, which toppled trees. And they showed that most of the deaths happened in counties where the risk of hurricane fatalities had been considered low, according to data from the Federal Emergency Management Agency. (Fortin, Nostrant, Taft and Underwood, 2/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF